Share Name Share Symbol Market Type Share ISIN Share Description
Medica Group plc LSE:MGP London Ordinary Share GB00BYV24996 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +3.50p +1.69% 210.50p 210.00p 218.00p 209.00p 209.00p 209.00p 72,005 16:35:03
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 28.5 4.3 3.3 63.4 233.89

Medica Grp (MGP) Latest News

More Medica Grp News
Medica Grp Takeover Rumours

Medica Grp (MGP) Share Charts

1 Year Medica Grp Chart

1 Year Medica Grp Chart

1 Month Medica Grp Chart

1 Month Medica Grp Chart

Intraday Medica Grp Chart

Intraday Medica Grp Chart

Medica Grp (MGP) Discussions and Chat

Medica Grp Forums and Chat

Date Time Title Posts
29/10/201721:24Medica Group304
04/8/200912:33Mercury Group: Charts and Comment254
24/7/200814:11Mercury Group...A New Beginning.668
14/10/200516:59Mercury Group (Old Cater Barnard) A New Beginning254
16/4/200406:53Make My Day5

Add a New Thread

Medica Grp (MGP) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
16:45:32212.582,2894,866.03O
16:44:54212.585,11410,871.50O
16:35:03210.504761,001.98UT
16:02:15214.131,0002,141.25O
16:00:01215.009,00019,350.00O
View all Medica Grp trades in real-time

Medica Grp (MGP) Top Chat Posts

DateSubject
23/11/2017
08:20
Medica Grp Daily Update: Medica Group plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker MGP. The last closing price for Medica Grp was 207p.
Medica Group plc has a 4 week average price of 207p and a 12 week average price of 190p.
The 1 year high share price is 242p while the 1 year low share price is currently 170.25p.
There are currently 111,111,114 shares in issue and the average daily traded volume is 30,050 shares. The market capitalisation of Medica Group plc is £233,888,894.97.
22/10/2017
20:37
dibbs: Good post Velod. I think you have pretty much hit the nail on the head! I bought MGP thinking it would be a nice long term hold but with the hope that the share price would have appreciated a little more than it has by now! I bought around May when the chart looked pretty good and I thought there was some momentum evident but that soon fizzled out after my purchases! With hindsight I was a little hasty in taking a position as the PE is pretty rich. I have decided that MGP has loads of positives and with the advancement of time, coupled with IMHO a greater risk of an upside earnings surprise than downside that I would stay put. Hopefully future events here will make me a happier shareholder and persuade you that MGP is on the move! Cheers Dibbs
20/10/2017
21:08
velod: This post in response to The BigShortFella’s request to me on another forum and is in reply to BSFella. Have no position in this share, nor intention to take one, but now it’s been brought to my attention might put it on a watchlist somewhere, out of sheer Nosey-Parker-interest on my part. Hi BSFella, Had the impression you were a micro-cap guy so surprised this is a quarter billion-pound MCap company. As a trend follower, no I would not buy this, at this juncture, based solely on the share price action alone. Momentum is iffy; albeit with a recent bull trend initiated, but it’s yet to be established if THIS TIME it will hold and build. Can’t understand why as the company as distinct from the share price appears to be a right little belter. Have access to the Piotroski F-Score and (if anyone hasn’t heard of that just Google) was gobsmacked at how MGP, the business, scored. It only goes and achieves top marks! Not only top marks but flying colours too, kind of top Marks! The highest a company can achieve is 9 - and MGP is rated a right royal gold standard 9. You can’t get higher. And that tells me this is one well-run, mean machine business. That being the case, what the hell’s happened to the share price momentum? I’m not built for fundamentals, but things like Return On Capital and ROE are excellent – no wonder it scored so highly on the F-Score. The business per se, independent of the share price rating, is a stonking belter! So why am I not interested? The share price soared until mid-summer. What happened at the height of summer? Because since then the share price has been unimpressive. Why has the market withdrawn its admiration by turning its back on the SP? And why that big retrace today, Friday? Perhaps I should read the posts below; somebody must have an idea. Why has the market withdrawn its initial embrace? Is it the PE ratio? Does the market think the current PE ratio is unworthy and is holding back? It is above the market average but not that much, (Edit, Upon reflection, well - yes that much. It is a 'fair bit' above the average). Unless I trawled through analysts reports something about this share price level, irks the market. Trendlines: It is currently on a little bull rally, but it’s been on and off all summer like that and looks disappointing to me. I, personally don’t trust the share price so wouldn’t take a long position. nor a short position because the share price has no real momentum for either strategy to be reliable. Until a clear trend breaks AND holds it’s a sit it out on the side-lines job for me with this one. Great company. Rubbish share price momentum.
04/10/2017
10:04
dibbs: Some big trades gone through and the share price has edged upwards. Perhaps an overhang of stock cleared....Dibbs
18/9/2017
22:19
glasshalfull: The share price was down today because MGP failed to deliver sales in line with Investec's forecasts. Investec believe however that full year forecasts can be achieved. "H1 sales were weaker than we expected due to capacity constraints and the timing of contract renewals. Revenues rose 17%, with 6.5% growth in body parts reported. However x-ray sales fell 8% as resources were directed towards the higher value services. The company recruited a net 19 radiologists in the period, with a further 24 added post period-end, consequently we are confident FY estimates can be achieved." --- Hope this assists. I don't hold. Kind regards GHF
07/9/2017
15:10
lomax99: Shares magazine Medica is a premium growth story The NHS does not have enough radiologists to interpret potentially life-saving scans Teleradiology firm Medica (MGP) is expected to enjoy rapid growth thanks to a surge in demand and a lack of radiologists in the UK. Medica helps to provide early diagnosis of various diseases through its consultant radiologists who interpret computerised tomography (CT) and magnetic resonance imaging (MRI) scans. If these scans identify diseases earlier, it can improve treatment options and outcomes. Strong performance since IPO Berenberg says earnings before interest, tax, depreciation and amortisation and earnings per share are expected to grow at a compound annual growth rate of 16% and 20% respectively between 2017 and 2020. Medica has enjoyed a strong share price performance since its IPO on 21 March 2017 when it raised £121m to pay down borrowings. Since 22 March, the stock has rallied 16.9% to 219.2p. The company currently trades on a forecast 29.8 times earnings per share in the year to 31 December 2018, but Berenberg analyst Charles Weston thinks this premium valuation is ‘justifiedR17; in light of rapid growth. The analyst projects 8% growth per annum in the volume of CT and MRI scans handled by the company, which will be supported by a deficit of radiologists in the UK. There are 4.7 radiologists per 100,000 of the UK general population. This is materially below the Royal College of Radiologists’ target of 8 per 100,000, and is pushing up waiting lists. Outsourcing trends and pricing power One of the ways to tackle this issue is by outsourcing services. Weston says approximately 7% of CT/MRI scans are outsourced. Medica has a dominant position in the UK teleradiology market (50%) and this allows it to charge 5% to 10% more than its rivals. The analyst also highlights that 80% of all clinical decisions are underpinned by imaging and new clinical guidelines for quicker diagnosis of diseases such as cancer and dementia call for scans. Medica provides services to over 100 NHS trusts, as well as private hospitals and diagnostics imaging firms, and intends to expand its services to tackles conditions such as strokes. There are risks associated with the business. Medica needs to ensure it continues to recruit radiologists to meet demand as otherwise growth could be constrained. We were initially cautious on Medica’s dependence on the NHS and Weston also highlights the NHS exposure as a reason for some caution as 99% of sales are derived from NHS Trusts. Despite this nagging concern we are convinced high demand and low supply will drive Medica forward.
22/8/2017
20:56
thebigshortfella: Dan_the_Epic - I like the fact that you are challenging MGP. Am I right in assuming that you wouldn't trade MGP at its current share price?
12/6/2017
22:20
dibbs: Certainly some decent volume today but the share price remains pretty static. WJG exhibited very similar behavior before heading northwards with a breakout from around 120p to 180p. Just a bit of patience required before MGP has it's time IMHO. Dibbs
12/6/2017
09:46
thebigshortfella: lomax99 - do you have a view on this? The share price seems almost unnaturally static. Thanks
09/5/2017
14:05
opodio: Be 20 years before you rely on a computer to do it This is where artificial intelligence will play a key role in the next couple years. AI will not be diagnosing patients and replacing doctors — it will be augmenting their ability to find the key, relevant data they need to care for a patient and present it in a concise, easily digestible format. When a radiologist calls up a chest computed tomography (CT) scan to read, the AI will review the image and identify potential findings immediately — from the image and also by combing through the patient history related to the particular anatomy scanned. If the exam order is for chest pain, the AI system will call up: Share price Moving up now
04/1/2008
10:58
canny lass: Chancher6, I would have thought it will all come in one general announcement. Particulars of the acquisition. Proposed means to fund acquisition - Rights Issue. Share consolidation to justify 7.5p share price. Normally the price offered for the Rights issue is slightly discounted to the share price.
Medica Grp share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20171123 17:00:37